| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.4 | 6e-36 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-16 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-14 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-11 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-09 |